Skip to search formSkip to main contentSkip to account menu

temozolomide 180 MG Oral Capsule

Known as: TEMOZOLOMIDE 180 mg ORAL CAPSULE [Temozolomide], TEMOZOLOMIDE 180MG CAP, TEMOZOLOMIDE 180MG CAP [VA Product] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
4608Background: CAPTEM is an accepted regimen for patients (pts) with advanced pNETs. Single agent 177Lu-Octreotate PRRT is now a… 
2019
2019
Vesicle amine transport protein 1 (VAT1) has been reported as a pathogenic factor in a variety of tumors. VAT1 has been revealed… 
Highly Cited
2017
Highly Cited
2017
Importance Tumor-treating fields (TTFields) is an antimitotic treatment modality that interferes with glioblastoma cell division… 
Highly Cited
2016
Highly Cited
2016
Poly(ADP-ribose) polymerase inhibitors (PARPIs) kill cancer cells by trapping PARP1 and PARP2. Talazoparib, the most potent PARPI… 
Highly Cited
2015
Highly Cited
2015
Purpose: Rechallenge with temozolomide (TMZ) at first progression of glioblastoma after temozolomide chemoradiotherapy (TMZ/RT… 
Highly Cited
2012
Highly Cited
2012
The antitumor prodrug temozolomide (TMZ) decomposes in aqueous medium of pH≥7 but is relatively stable under acidic conditions… 
Highly Cited
1993
Highly Cited
1993
Temozolomide (8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4-(3H)-one) has shown promising activity in Phase I trials…